Continue on TOI App
Open App
OPEN APP

Eris buys 70% stake in Swiss Parenterals

NEW DELHI: Eris LifeSciences is acquiring a 51% stake in Swiss Parenterals, a sterile injectable manufacturer, for Rs 637.5 crore, to expand its footprint in the sterile injectables business.

Tired of too many ads?go ad free now
The company's promoter group will concurrently acquire an additional 19% in the company for Rs 237.5 crore, thereby bringing the total stake of Eris and its promoter group in the company to 70%, says a company statement.

The promoter group includes the company's CMD, Amit Bakshi, and others, including Inderjeet Singh Negi, Kaushal Shah and Rajendra Patel, a BSE filing said.

Stay informed with the latest Business News on Times of India. Explore updates on International Business, gain insights with Financial Literacy tips, and make use of Financial Calculators. Don’t forget to check the list of Bank Holidays in 2025, including Bank Holidays in January.


Ready to Master Stock Valuation? ET’s Workshop is just around the corner!

Start a Conversation

Post comment
Continue Reading
Follow Us On Social Media
end of article
More Trending Stories
Visual Stories
More Visual Stories
UP NEXT
Do Not Sell Or Share My Personal Information